Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Goldberg

Showing results (71-80 of 359) with videos related to

Pageof 36
Sort By:
The Oncologist|January 17, 2009
Commentary: Disclosure in oncology -- to whom does the truth belong?William A Wood, Mary S McCabe, Richard M Goldberg
Clinical Advances in Hematology & Oncology : H&O|December 2, 2006
The role of targeted therapy in the treatment of colorectal cancerRichard M Goldberg, Herbert I Hurwitz, Charles S Fuchs
Molecular Cancer Therapeutics|January 14, 2009
Platinum neurotoxicity pharmacogeneticsSarah R McWhinney, Richard M Goldberg, Howard L McLeod
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Reply to J.N. Primrose et al and C.-H. KöhneBernard M Nordlinger, Graeme J Poston, Richard M Goldberg
Clinical Colorectal Cancer|August 9, 2011
A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancerAmy S Lucas, Bert H O'Neil, Richard M Goldberg
Therapeutic Advances in Medical Oncology|July 17, 2013
What is the optimal neo-adjuvant treatment for liver metastasis?Sigurdis Haraldsdottir, Christina Wu, Mark Bloomston, et al.
Journal of Oncology Practice|July 2, 2010
When the family requests withholding the diagnosis: who owns the truth?Mary S McCabe, William A Wood, Richard M Goldberg
Clinical Advances in Hematology & Oncology : H&O|March 25, 2006
Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directionsRichard M Goldberg, Herbert I Hurwitz, Charles S Fuchs
Clinical Advances in Hematology & Oncology : H&O|September 21, 2005
Cetuximab in the treatment of colorectal cancerRichard M Goldberg, Alan P Venook, Richard L Schilsky
Clinical Colorectal Cancer|November 28, 2007
A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patientsHanna K Sanoff, Richard M Goldberg, Michael P Pignone
Pageof 36

Showing results (71-80 of 359) with videos related to

Sort By:
Pageof 36
The Oncologist|January 17, 2009
Commentary: Disclosure in oncology -- to whom does the truth belong?William A Wood, Mary S McCabe, Richard M Goldberg
Clinical Advances in Hematology & Oncology : H&O|December 2, 2006
The role of targeted therapy in the treatment of colorectal cancerRichard M Goldberg, Herbert I Hurwitz, Charles S Fuchs
Molecular Cancer Therapeutics|January 14, 2009
Platinum neurotoxicity pharmacogeneticsSarah R McWhinney, Richard M Goldberg, Howard L McLeod
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Reply to J.N. Primrose et al and C.-H. KöhneBernard M Nordlinger, Graeme J Poston, Richard M Goldberg
Clinical Colorectal Cancer|August 9, 2011
A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancerAmy S Lucas, Bert H O'Neil, Richard M Goldberg
Therapeutic Advances in Medical Oncology|July 17, 2013
What is the optimal neo-adjuvant treatment for liver metastasis?Sigurdis Haraldsdottir, Christina Wu, Mark Bloomston, et al.
Journal of Oncology Practice|July 2, 2010
When the family requests withholding the diagnosis: who owns the truth?Mary S McCabe, William A Wood, Richard M Goldberg
Clinical Advances in Hematology & Oncology : H&O|March 25, 2006
Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directionsRichard M Goldberg, Herbert I Hurwitz, Charles S Fuchs
Clinical Advances in Hematology & Oncology : H&O|September 21, 2005
Cetuximab in the treatment of colorectal cancerRichard M Goldberg, Alan P Venook, Richard L Schilsky
Clinical Colorectal Cancer|November 28, 2007
A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patientsHanna K Sanoff, Richard M Goldberg, Michael P Pignone
Pageof 36